» Articles » PMID: 1079205

The Antigenicity of Carcinoembryonic Antigen in Man

Overview
Journal Int J Cancer
Specialty Oncology
Date 1975 Feb 15
PMID 1079205
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Binding of globulins to -125I CEA was detected in 10 of 24 sera from patients with cancer, 13 of 26 sera from blood donors, and 7 of 27 supernates of tumor-cell suspensions. Binding was predominantly by IgM in 10 of 14 sera tested by radioimmunoelectrophoresis. Binding was inhibited by 6 ng unlabelled CEA in one instance only, and by adsorption with blood group A erythrocytes in three cases. Binding was not increased in dialysed precipitates formed by ammonium sulfate at pH 2.5, while there was increased binding in precipitates of complexes of CEA and heterologous anti-CEA. These results confirm that human IgM binds to CEA, and in some cases binding appears to be mediated by antibodies to blood group A. However, the binding is weak and appears to be of low affinity. This suggests that binding of CEA by immunoglobulins represents cross-reactivity by antibodies to similar antigens, of which blood group A is one example.

Citing Articles

Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

Zbar A, Lemoine N, Wadhwa M, Thomas H, Snary D, Kmiot W Br J Cancer. 1998; 77(5):683-93.

PMID: 9514045 PMC: 2149974. DOI: 10.1038/bjc.1998.114.


Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer.

Schlom J, Kantor J, Abrams S, Tsang K, Panicali D, HAMILTON J Breast Cancer Res Treat. 1996; 38(1):27-39.

PMID: 8825120 DOI: 10.1007/BF01803781.


Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract?.

Staab H, Anderer F, Stumpf E, Fischer R Br J Cancer. 1980; 42(1):26-33.

PMID: 7426328 PMC: 2010478. DOI: 10.1038/bjc.1980.199.


[Relapse prognosis for patients with adenocarcinoma of the gastrointestinal tract on the basis of carcinoembryonic antigen (CEA) and its circulating immune complexes (author's transl)].

Staab H, Anderer F, Stumpf E, Fischer R Klin Wochenschr. 1980; 58(3):125-33.

PMID: 7366126 DOI: 10.1007/BF01477269.


Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.

Chester K, Begent R Clin Exp Immunol. 1984; 58(3):685-93.

PMID: 6509799 PMC: 1577103.